iMD Companies, Inc. (OTC: ICBU) announced today that it has begun advanced due diligence on two potential acquisition targets: one in the cryptocurrency infrastructure sector and another in the medical technology space. The company, based in Rancho Cordova, CA, is focusing on opportunities that align with its strategic goal of investing in high-growth industries supported by scalable technologies and long-term market demand.
According to the press release, these potential acquisitions could strengthen iMD's position across emerging sectors and support future revenue expansion. Richard Wilson, CEO of iMD Companies, stated, 'We are encouraged by the progress we’ve made in evaluating these opportunities. Our approach remains disciplined and focused on identifying assets that can deliver sustainable growth and long-term value for our shareholders.'
The due diligence process is ongoing, with completion anticipated in the coming weeks. iMD Companies will provide updates as appropriate as evaluations progress. The company remains committed to maintaining transparency with its shareholders and will continue to communicate material developments in a timely manner.
iMD Companies, Inc. is a Florida corporation focused on acquisitions and technology in the cryptocurrency, blockchain, and application development markets. More information can be found on their website at imdcompaniesinc.com or on OTC Markets. The company also provides real-time updates via X at @imd_inc.
The announcement comes as iMD seeks to expand its footprint in high-growth sectors. The company’s focus on cryptocurrency infrastructure and medical technology reflects broader market trends, as both industries have seen increased investment and innovation. The potential acquisitions could provide iMD with new revenue streams and technological capabilities.
Forward-looking statements in the release indicate that actual results may differ due to various risks and uncertainties. The company does not undertake any obligation to update forward-looking statements. This development underscores iMD's proactive approach to capitalizing on emerging opportunities in the evolving digital and healthcare landscapes.
